All the news articles and press releases in one place.


Date / Time Source Company % Chg Sector Market Cap Announcement
17Jan17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Appointment of CFO and Head of Clinical Operations
17Jan17 07:00 RNS Evgen Pharma -4.14% Health £4.60m First Patient Dosed in Breast Cancer Trial
11Jan17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Positive DSMB Review of SAS Trial
05Dec16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Half Yearly Report
17Nov16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Notice of Interim Results
01Nov16 12:30 RNS Evgen Pharma -4.14% Health £4.60m Grant of Options
15Sep16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Update re SFX-01 Data at ECTRIMS 2016
08Sep16 15:30 RNS Evgen Pharma -4.14% Health £4.60m Presentation of SFX-01 Data at ECTRIMS 2016
24Aug16 15:15 RNS Evgen Pharma -4.14% Health £4.60m Orphan Designation in the USA in SAH
17Aug16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Approval for Phase II Study in Breast Cancer
24Jun16 15:36 RNS Evgen Pharma -4.14% Health £4.60m Result of AGM
09Jun16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Grant of Options
02Jun16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Posting of Annual Report and AGM Notice
31May16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Final Results
09May16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Notification of Preliminary Results
03May16 07:00 RNS Evgen Pharma -4.14% Health £4.60m First Patient Dosed in Phase II Trial
02Mar16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Approval of Phase II Clinical Trial in SAH
19Jan16 15:23 RNS Evgen Pharma -4.14% Health £4.60m Correction: Director Share Purchases
19Jan16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Director Share Purchases
11Jan16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Exercise of Options
04Jan16 07:00 RNS Evgen Pharma -4.14% Health £4.60m Appoints Chief Medical Officer
07Dec15 07:00 RNS Evgen Pharma -4.14% Health £4.60m Half Yearly Report
23Nov15 07:00 RNS Evgen Pharma -4.14% Health £4.60m Expands Pipeline with Novel Compounds
16Nov15 07:00 RNS Evgen Pharma -4.14% Health £4.60m Notification of Half Year Results
23Oct15 11:45 RNS Evgen Pharma -4.14% Health £4.60m Notification of Major Interest in Shares
21Oct15 07:00 RNS Evgen Pharma -4.14% Health £4.60m First Day of Dealings
Date / Time Source Company % Chg
17Jan17 07:00 RNS Evgen Pharma -4.14%
Appointment of CFO and Head of Clinical Operations
17Jan17 07:00 RNS Evgen Pharma -4.14%
First Patient Dosed in Breast Cancer Trial
11Jan17 07:00 RNS Evgen Pharma -4.14%
Positive DSMB Review of SAS Trial
05Dec16 07:00 RNS Evgen Pharma -4.14%
Half Yearly Report
17Nov16 07:00 RNS Evgen Pharma -4.14%
Notice of Interim Results
01Nov16 12:30 RNS Evgen Pharma -4.14%
Grant of Options
15Sep16 07:00 RNS Evgen Pharma -4.14%
Update re SFX-01 Data at ECTRIMS 2016
08Sep16 15:30 RNS Evgen Pharma -4.14%
Presentation of SFX-01 Data at ECTRIMS 2016
24Aug16 15:15 RNS Evgen Pharma -4.14%
Orphan Designation in the USA in SAH
17Aug16 07:00 RNS Evgen Pharma -4.14%
Approval for Phase II Study in Breast Cancer
24Jun16 15:36 RNS Evgen Pharma -4.14%
Result of AGM
09Jun16 07:00 RNS Evgen Pharma -4.14%
Grant of Options
02Jun16 07:00 RNS Evgen Pharma -4.14%
Posting of Annual Report and AGM Notice
31May16 07:00 RNS Evgen Pharma -4.14%
Final Results
09May16 07:00 RNS Evgen Pharma -4.14%
Notification of Preliminary Results
03May16 07:00 RNS Evgen Pharma -4.14%
First Patient Dosed in Phase II Trial
02Mar16 07:00 RNS Evgen Pharma -4.14%
Approval of Phase II Clinical Trial in SAH
19Jan16 15:23 RNS Evgen Pharma -4.14%
Correction: Director Share Purchases
19Jan16 07:00 RNS Evgen Pharma -4.14%
Director Share Purchases
11Jan16 07:00 RNS Evgen Pharma -4.14%
Exercise of Options
04Jan16 07:00 RNS Evgen Pharma -4.14%
Appoints Chief Medical Officer
07Dec15 07:00 RNS Evgen Pharma -4.14%
Half Yearly Report
23Nov15 07:00 RNS Evgen Pharma -4.14%
Expands Pipeline with Novel Compounds
16Nov15 07:00 RNS Evgen Pharma -4.14%
Notification of Half Year Results
23Oct15 11:45 RNS Evgen Pharma -4.14%
Notification of Major Interest in Shares
21Oct15 07:00 RNS Evgen Pharma -4.14%
First Day of Dealings
Date / Time Company % Chg
17Jan17 07:00 Evgen Pharma -4.14%
Appointment of CFO and Head of Clinical Operations
17Jan17 07:00 Evgen Pharma -4.14%
First Patient Dosed in Breast Cancer Trial
11Jan17 07:00 Evgen Pharma -4.14%
Positive DSMB Review of SAS Trial
05Dec16 07:00 Evgen Pharma -4.14%
Half Yearly Report
17Nov16 07:00 Evgen Pharma -4.14%
Notice of Interim Results
01Nov16 12:30 Evgen Pharma -4.14%
Grant of Options
15Sep16 07:00 Evgen Pharma -4.14%
Update re SFX-01 Data at ECTRIMS 2016
08Sep16 15:30 Evgen Pharma -4.14%
Presentation of SFX-01 Data at ECTRIMS 2016
24Aug16 15:15 Evgen Pharma -4.14%
Orphan Designation in the USA in SAH
17Aug16 07:00 Evgen Pharma -4.14%
Approval for Phase II Study in Breast Cancer
24Jun16 15:36 Evgen Pharma -4.14%
Result of AGM
09Jun16 07:00 Evgen Pharma -4.14%
Grant of Options
02Jun16 07:00 Evgen Pharma -4.14%
Posting of Annual Report and AGM Notice
31May16 07:00 Evgen Pharma -4.14%
Final Results
09May16 07:00 Evgen Pharma -4.14%
Notification of Preliminary Results
03May16 07:00 Evgen Pharma -4.14%
First Patient Dosed in Phase II Trial
02Mar16 07:00 Evgen Pharma -4.14%
Approval of Phase II Clinical Trial in SAH
19Jan16 15:23 Evgen Pharma -4.14%
Correction: Director Share Purchases
19Jan16 07:00 Evgen Pharma -4.14%
Director Share Purchases
11Jan16 07:00 Evgen Pharma -4.14%
Exercise of Options
04Jan16 07:00 Evgen Pharma -4.14%
Appoints Chief Medical Officer
07Dec15 07:00 Evgen Pharma -4.14%
Half Yearly Report
23Nov15 07:00 Evgen Pharma -4.14%
Expands Pipeline with Novel Compounds
16Nov15 07:00 Evgen Pharma -4.14%
Notification of Half Year Results
23Oct15 11:45 Evgen Pharma -4.14%
Notification of Major Interest in Shares
21Oct15 07:00 Evgen Pharma -4.14%
First Day of Dealings